|
Market Closed -
Other stock markets
|
After hours 20:00:00 | |||
| 477.36 USD | +0.90% |
|
460.64 | -3.50% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 554.91 | +16.25% | 23 | ||||||
| 1,270.37 | +6.22% | 27 | ||||||
| 270.59 | +2.73% | 22 | ||||||
| 267.79 | +3.25% | 28 | ||||||
| 361.72 | +1.86% | 18 | ||||||
| 153.66 | -1.09% | 21 | ||||||
| 212.16 | +25.51% | 22 | ||||||
| 317.2 | -1.06% | 24 | ||||||
| 356.69 | -5.15% | 29 | ||||||
| 157.52 | +21.81% | 27 | ||||||
| 28.75 | +17.15% | 26 | ||||||
| 62.96 | +1.4% | 24 | ||||||
| 96.14 | +26.45% | 23 | ||||||
| 21.39 | +11.44% | 20 | ||||||
| 9,700 | +30.8% | 15 | ||||||
| 6,262.69 | +10.88% | 16 | ||||||
| 80.33 | +50.3% | 15 | ||||||
| 54.92 | +19.23% | 18 | ||||||
| 4.142 | +13.96% | 17 | ||||||
| Average | 1,064.94 | +13.26% | 22 | ||||||
| Weighted average by Cap. | 710.99 | +7.68% | 24 |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
